Usa covid-19 testing information vaccine Usa

Doubts emerge over Oxford Covid-19 vaccine after it 'only worked well in younger people'

Reading now: 937
www.mirror.co.uk

Shocking doubts have emerged about the Oxford Covid-19 vaccine after it only worked well in younger age groups. Oxford University and pharma giant AstraZeneca announced to much fanfare this week that clinical trials were up to 90% effective.

However the group of trial participants who achieved this success rate had actually been given an initial half dose - a blunder first revealed by the Mirror in June.

The trial continued and the main group who were given two full doses only recorded an effectiveness rate of 62%. It has now emerged the smaller group of less than 3,000 out of 24,000 trial participants on the half-dose-full-dose regime - which recorded the 90% effectiveness rate - were all under 55.

Read more on mirror.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA